💉 IUI vs IVF for Unexplained Infertility: Which to Try First

Unexplained infertility — when a complete workup finds no clear cause for a couple's difficulty conceiving — affects roughly 15 to 30 percent of couples seeking fertility care. The frustrating part: no diagnosis means no obvious treatment target. Both IUI (intrauterine insemination) and IVF (in vitro fertilization) can help. Which to try first is one of the most actively debated questions in reproductive medicine, and the answer in 2026 depends heavily on the patient's age.

What "Unexplained Infertility" Actually Means

The diagnosis requires:

• Normal ovulation, confirmed by cycle tracking, blood work, or ovulation tests
• At least one open fallopian tube, confirmed by hysterosalpingogram (HSG) or hysterosalpingo-contrast sonography (HyCoSy)
• Normal semen analysis, by WHO 2021 criteria, ideally on two samples
• Normal ovarian reserve for the patient's age (AMH, antral follicle count)
• No significant uterine, ovarian, or pelvic pathology on imaging
• At least 12 months of regular unprotected intercourse without conception (6 months if the female partner is 35 or older)

If all those boxes are checked and conception has not happened, you have unexplained infertility.

The Three Main Treatment Paths

Expectant management with timed intercourse

For younger couples (under 35) with a short duration of infertility, continued natural attempts with optimized timing remain a reasonable first step. Per-cycle pregnancy rates are around 2 to 4 percent, but cumulative chances over 6 months are not negligible.

IUI with ovarian stimulation

The female partner takes oral medication — usually letrozole (Femara) or clomiphene citrate (Clomid) — to recruit 1 to 3 follicles. Around ovulation, prepared sperm is placed directly into the uterus through a thin catheter. Per-cycle pregnancy rates are typically 8 to 15 percent depending on age and protocol.

IVF

Full stimulation, retrieval, lab fertilization, and transfer. Per-cycle live birth rates in unexplained infertility are typically 30 to 50 percent under age 35, dropping with age.

The FASTT Trial: Why Conventional Wisdom Changed

The FASTT trial (Fast Track and Standard Treatment Trial), published in 2010 in Fertility and Sterility, randomized 503 couples with unexplained infertility to either a conventional ladder (clomiphene-IUI, then gonadotropin-IUI, then IVF) or an accelerated track (clomiphene-IUI, then directly to IVF, skipping the gonadotropin-IUI step).

The accelerated track:

• Achieved pregnancy 3 months faster on average
• Had similar or better cumulative live birth rates
• Was more cost-effective overall (because gonadotropin-IUI is expensive and has higher multiple pregnancy rates)

This study shifted practice toward earlier IVF for many couples.

The AMIGOS Trial: Letrozole vs Clomid vs Gonadotropins for IUI

The AMIGOS trial (Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation), published in 2014 in NEJM, randomized 900 couples to clomiphene-IUI, letrozole-IUI, or gonadotropin-IUI.

Key findings:

• Gonadotropin-IUI had the highest pregnancy rate but a 32 percent multiple pregnancy rate (mostly twins) — unacceptably high in current practice
• Clomiphene-IUI and letrozole-IUI had similar pregnancy rates with lower multiples risk
• Letrozole-IUI is now generally preferred over clomiphene because of similar effectiveness with lower multiples and better endometrial effects

Gonadotropin-IUI has largely fallen out of favor because of the multiples risk.

Age-Based Decision Framework

Most 2024-2025 ASRM guidance and clinical practice can be summarized like this:

Under age 35

Three to four cycles of letrozole-IUI is reasonable before moving to IVF. Total time invested: roughly 4 to 6 months.

Age 35 to 37

Two to three cycles of letrozole-IUI, then IVF. Time is becoming a real factor.

Age 38 to 40

One to two cycles of letrozole-IUI may be tried, but moving to IVF after a single IUI failure is increasingly common. Some clinicians recommend going directly to IVF.

Age 41 and older

Most clinicians recommend going directly to IVF, with serious consideration of PGT-A to address rapidly rising aneuploidy rates.

Cost Comparison

• Letrozole-IUI: typically $500 to $2,000 USD per cycle including medications and monitoring (Canadian costs comparable in CAD)
• IVF: typically $12,000 to $25,000 per cycle in North America

For patients without insurance coverage, the cost gap can justify trying IUI first even when per-cycle success is lower. For patients with coverage or in mandate states, the calculation shifts.

The Cumulative Math

A pragmatic way to think about it: three IUI cycles with 12 percent per-cycle success gives a cumulative success rate of roughly 33 percent. One IVF cycle at age 35 with 45 percent live birth rate beats that with one shot. The trade-off is cost, intensity, and side effects.

Insurance Considerations

Many US state mandates and Canadian provincial programs cover IUI before they will cover IVF. Ontario's OFP covers unlimited IUI but only one funded IVF cycle, so many patients exhaust IUI options first by program design.

Talking to Your Doctor

Key questions:

• Given my age and diagnostic profile, what is my per-cycle IUI success estimate at this clinic?
• After how many failed IUI cycles do you recommend moving to IVF?
• Are there reasons specific to my case to skip IUI?
• How does insurance or provincial coverage affect the path?

Confirm the treatment plan with your reproductive endocrinologist. To compare clinic success rates by age, browse the Fertility Link Navigator.